Close Menu

NEW YORK (360Dx) – French diagnostic and theranostics firm Theradiag announced on Wednesday that it has signed an agreement to supply its Lisa Tracker monitoring kits for use in monitoring responses to biosimilar drugs sold by French generic drug maker Biogaran.

Lisa Tracker kits are designed to monitor serum levels of circulating TNF-alpha, prescribed TNA-alpha inhibitors, and drug-neutralizing antibodies to help physicians manage treatment regimens.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.